Evidence history
Follow the evidence behind a claim
See when an assessment was recorded, what it concluded and which sources support it. Save subjects in this browser to find their records again.
This history begins on November 15, 2026. Its first entries are baseline assessments of older research. No later evidence updates or historical grade changes have been recorded here yet. A baseline entry does not mean a conclusion changed.
Your evidence watchlist
Save a subject to find its evidence assessment again. This list stays in this browser. It does not send notifications or subscribe you to email.
Loading saved subjects…
- Did a daily multivitamin prevent cancer in COSMOS?
Assessment: 2026-11-15 · Randomized human trial
Multivitamin evidence record - What did VITAL find about fish oil and heart events?
Assessment: 2026-11-15 · Randomized human trial
Omega-3 evidence record - Did glucosamine relieve knee pain in GAIT?
Assessment: 2026-11-15 · Randomized human trial
Glucosamine evidence record - How large was the magnesium bisglycinate sleep result?
Assessment: 2026-11-15 · Randomized human trial
Magnesium evidence record - What does the psilocybin mouse survival result mean?
Assessment: 2026-11-15 · Mouse and cell experiments
Psilocybin evidence record
Public assessment history
· Baseline assessment
Did a daily multivitamin prevent cancer in COSMOS?
COSMOS did not establish a reduction in total invasive cancer during its follow-up. This result does not settle every use of a multivitamin.
First entry in this evidence history. This is a dated assessment of existing research, not a newly published study or a change to a library grade.
Conclusion changed: not applicable — first entry.
· Baseline assessment
What did VITAL find about fish oil and heart events?
VITAL did not establish a reduction in its primary cardiovascular outcome. A positive result for prescription EPA in a different population cannot be assumed to apply to an ordinary fish-oil supplement.
First entry in this evidence history. This is a dated assessment of existing research, not a newly published study or a change to a library grade.
Conclusion changed: not applicable — first entry.
· Baseline assessment
Did glucosamine relieve knee pain in GAIT?
GAIT did not establish an overall pain benefit for glucosamine hydrochloride alone. Its exploratory combination-treatment subgroup is not proof that glucosamine alone works.
First entry in this evidence history. This is a dated assessment of existing research, not a newly published study or a change to a library grade.
Conclusion changed: not applicable — first entry.
· Baseline assessment
How large was the magnesium bisglycinate sleep result?
The trial found a small additional improvement in reported insomnia symptoms over four weeks. It did not establish an objective sleep benefit or superiority to other magnesium forms.
First entry in this evidence history. This is a dated assessment of existing research, not a newly published study or a change to a library grade.
Conclusion changed: not applicable — first entry.
· Baseline assessment
What does the psilocybin mouse survival result mean?
This study cannot establish a human lifespan benefit. More treated mice survived to the study endpoint, but the experiment ended before their full lifespans were observed.
First entry in this evidence history. This is a dated assessment of existing research, not a newly published study or a change to a library grade.
Conclusion changed: not applicable — first entry.